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Abstract 
Confocal Raman Microscopy (CRM) in combination with a photophysical investigation has been employed to give insight into the 
interaction between calcium oxalate monohydrate (COM) and a series of tetrazole containing crystal growth modifier’s (CGM’s), in 
conjunction with characterisation of morphological changes using scanning electron and optical microscopy. The tetrazole CGM’s 
were found to interact by surface adsorption with minimal morphological changes to the COM crystals however, significant 
interactions via chemisorption were observed; it was discovered that the chemisorption is sufficiently strong for aggregation of the 
tetrazole species to occur within the crystal during crystallisation.  
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Introduction 
The formation of stones in the kidney, bladder or urinary 
tract1 (urolithiasis) are undesirable biological crystallisation 
events that can occur within the human body; in particular, 
kidney stone (renal calculi) formation is very common, with 1 
in 10 people affected in their lifetime2. The most common 
type of human kidney stones are calcium containing stones, 
the major constituent of which is COM (CaC2O4·H2O) at 
70%3. COM is the thermodynamically stable phase of 
calcium with oxalate at room temperature but has two other 
meta-stable phases, the dihydrate and the trihydrate, with 
the dihydrate also being commonly present in human kidney 
stones while the trihydrate is uncommon. Currently, few 
medicines used for the treatment of kidney stones do not 
have risks inherent with their use and thus surgical removal 
and other techniques including extracorporeal shock-wave 
lithotripsy (ESWL) and medical expulsive therapy (MET) are 
used to combat the already grown calculi4. Research in the 
field, therefore, focuses on kidney stone prevention 
employing crystal growth modifiers (CGM’s) as a means of 
controlling kidney stone formation. Those inflicted with the 
condition would benefit greatly from the development of 
therapeutics that hinder the formation of nuclei or 
suppresses their growth. Crystal growth modifiers recently 
studied include but are not limited to carboxylic acids, 
calixarenes, proteins and polymers5–8. 
Recently researchers have been utilising the bioisostere 
nature of carboxylic acids and tetrazoles9–13 to investigate 
the effect the tetrazole moiety has in medicine, and more 
recently in the field of crystal growth modification. Before our 
group started investigating tetrazoles as modifiers, they had 
not been used as crystal growth modifiers; now crystal 
systems have been investigated including, barium sulfate, 
calcium carbonate14, and calcium oxalate15, all of which were 
discovered to be inhibited by the presence of tetrazoles 
during crystallisation. The tetrazole species used in this 
study are shown in Figure 1. This study, in which we present 
our preliminary results, is a continuation and expansion of 
the work mentioned above to try to elucidate the mechanism 
of interaction between COM crystals and the tetrazole 
species during crystallisation. We have utilised the 
capabilities of Confocal Raman Microscopy (CRM) and a 
photophysical investigation to provide insight into the 
mechanism of COM modification in the presence of a series 
of tetrazoles which have varying degrees of impact as 
CGM’s, the morphology changes were monitored by optical 
microscopy and SEM.  
 
Figure 1. Tetrazoles species structures used as CGM’s (named 
from top left down to top right down) 5-(4-Pyridyl)-1H-tetrazole 
(TzpPyrH, 6.84 mM), 5-(3-Pyridyl)-1H-tetrazole (TzmPyrH, 6.84 
mM), 5-(2-Pyridyl)-1H-tetrazole (TzoPyrH, 6.84 mM), 5-(3-Pyrizine)-
1H-tetrazole (TzPyzH, 6.88 mM), 5-(4-Bromophenyl)-1H-tetrazole 
(TBrPhH, 4.51 mM), 5-(4-methoxyphenyl)-1H-tetrazole 
(TzMeoxPhH, 5.78 mM). 5-(4-phenol)-1H-tetrazole (TzPhoH, 6.22 
mM). 
Results and discussion 
CRM investigation of COM in the presence of CGM’s. 
As has been previously reported15, tetrazoles have been 
found to change the morphology of COM crystals but 
seemingly through different mechanisms of interaction than 
their carboxylic acid equivalent counter-parts.  
This manuscript looks at understanding the interactions with 
similarly sized molecules as shown in Figure 1, with 
emphasis on the adsorption of the molecules to the crystal. 
The tetrazole species TzmeoxPh- will be used as the 
exemplary CGM throughout this manuscript for clarity. 
Firstly, the morphology of control crystals for our system are 
shown in Figure 2A, mostly twinned COM crystals between 
10 and 15 µm long, ~5 µm wide, ~8µm deep. Upon addition 
of all of the CGM’s above in Figure 1, reduction in the 
number of crystals is evident with some additives 
suppressing nucleation to such significant levels few 
particles could be found to analyse. The most potent 
inhibitors were TzoPyr-, TzBrPh- and TzmeoxPh-, each 
showing the greatest reduction of nuclei formed at their given 
concentrations; see supplementary Figure S1†-S3† for SEM 
images of the series and Table S1† for quantitative data for 
the series. Fig S3† illustrates the significant drop in the 
amount of particles due to the presence of many of the 
CGM’s. However, due to the reduction in the number of 
nuclei during crystallisation, the particles present are 
subsequently larger in size than that of the control COM 
crystals. Interestingly single crystals now dominate instead of 
the more common twinned crystals shown in the control 
example. Negligible morphological changes were seen with 
this series of tetrazoles however, significant impacts on the 
nucleation of the crystals was clearly evidenced (Table S1†). 
The Raman spectra presented in Figure 3 correspond to the 
COM formed under control conditions and in the presence of 
the TzmeoxPh- species. In the spectra provided the 
evidence of an interaction between COM and the tetrazole 
will be elucidated. Figure 3A, represents the Raman signal 
collected at the surface of a control COM crystal, it shows 
the characteristic peaks given for COM from the literature16 
at ~1470 cm-1, 1490 cm-1 and ~500 cm-1. The doublet at 
1470 cm-1 and 1490 cm-1 are characteristic of the 
monohydrate phase and not of the dihydrate or trihydrate 
phase for calcium oxalate. Figure 3B, displays a typical 
Raman spectrum for COM grown in the presence of our 
tetrazole species; in this case, TzmeoxPh-. The 
characteristic peaks for COM are still present but the signals 
are diminished in intensity due to the lowering of laser 
intensity to avoid exciting the tetrazole species (which 
fluoresces quite strongly in the regions where the 
characteristic peaks are visible). Figure 3B’s spectrum was 
taken at the surface of the crystal, which in contrast to Figure 
3C illustrates the capabilities of the CRM; this spectrum was 
taken a few micrometres within the crystal using the confocal 
ability of the instrument and allows for the observation of the 
fluorescence and Raman signals from the tetrazole at 
subsurface layers. The presence of these Raman vibrational 
frequencies indicates we have tetrazole species present 
within the crystals and not solely adsorbed to the surface, 
otherwise we would have observed a similar signal present 
for Figure 3B. For all the Raman spectra collected containing 
CGM’s, the main signals for the tetrazole species are found 
at ~1340cm-1 and 1600cm-1, these peaks are believed to 
belong to either the C-N or N-N stretching frequencies of the 
tetrazole, see Figure 3S† for the Raman of TzmeoxPhH 
only, which due to the process of adsorption has 
characteristic peaks that are different in position to those 
shown here. As mentioned above, the laser intensity was 
reduced in order to see the structure of these bands and  
Figure 2. SEM images of COM crystals, A) Control crystals, B) 
Crystals grown in the presence of TzmeoxPh- (5.78 mM). 
upon increasing the intensity of the laser, the fluorescent 
properties of the tetrazole species mask the structured peaks 
for both the tetrazole and COM. Figure 3D fully exemplifies 
why CRM has been selected as the technique used to 
investigate the presence of the tetrazole species within the 
COM crystals. As presented, the Y-axis indicates the 
intensity of the chosen Raman signals monitored during 
collection of the spectrum against the distance through the 
crystal (in micrometres, on the X-axis).  CRM allowed us to 
plot the intensity of the characteristic signal for the COM 
(blue trace – 1470 cm-1) and the tetrazole (red trace – 1340 
cm-1) allowing for a comparison between the two species’ 
intensities with respect to the position inside the COM 
crystal. This allows us to determine, with confidence, the 
location of the tetrazole species within the crystal itself. The 
tetrazole species have been found to reside closer to the 
surface of the COM crystals and relatively less found 
towards the centre of the crystal, the working hypothesis for 
this observation is that at the early stages of crystallisation i) 
the crystal faces of COM are not well developed for the 
tetrazole to adsorb onto specific faces and ii) during this time 
competition between the oxalate and tetrazole species 
occurs, which favours the oxalate species due to the initial 
high supersaturation. The interaction between the tetrazole 
and crystal is believed to occur via adsorption to the surface 
and subsequent growth of the COM around the tetrazole 
species resulting in what is observed in our system; the 
tetrazole species being included into the crystal itself as 
verified by our confocal Raman spectroscopy. 
 
Figure 3. Confocal Raman Spectra A) At surface of control COM crystals, B) Of COM crystals grown in the presence of TzmeoxPh- (5.78 mM), C) 
Raman spectrum taken within COM crystals grown in the presence of TzmeoxPh- (5.78 mM), D) Intensity of main characteristic Raman signals 
against the position each individual confocal Raman spectrum was taken, blue trace belongs to the COM crystals characteristic peak (~1470cm-1), 
while the red trace belongs to the tetrazole characteristic peak (~1340 cm-1), the black vertical lines represent the location of the crystal surfaces, at 















Figure 4. Emission and excitation profiles of TzmeoxPhH in four different states (orange trace corresponds to excitation, blue to emission). A) 
TzmeoxPh- (10-6M) in water, B) TzmeoxPhH solid state profile C) COM crystals profile grown in the presence of TzmeoxPh- and D) Profile of 
TzmeoxPh- dispersed in a PMMA polymer. 
Photophysical investigation of tetrazole species within 
COM crystals 
As mentioned above, what was common across the series of 
tetrazoles was the presence of very fluorescent Raman 
signals when the crystals were not washed before Raman 
analysis see Figure 4S†. This led us to subsequently wash 
the crystals with water. In all cases this removed the surface 
Raman signal we were seeing, which corresponds to the 
removal of surface adsorbed (physisorbed) tetrazolate 
species. What was more surprising was when we used the 
confocal properties of the Raman spectrometer to probe the 
crystal we found that significant Raman signals from 
tetrazole species were still present. This structured Raman 
signal is proposed to be due to chemisorbed tetrazolate 
species within the COM crystal.  
The presence of the tetrazole species within the crystals was 
investigated further through a photophysical investigation (as 
tetrazoles are known to be emissive) and the results are as 
follows: during the adsorption to the surface of the COM 
crystals, the tetrazole molecules aggregate together and this 
process results in not only the Raman signals we report 
above, but also the emission and excitation profiles seen in 
Figure 4. The excitation and emission spectra are presented 
in each image A through D for the tetrazole TzmeoxPhH in 
four different environments. Figure 4A shows the tetrazole 
species alone in an aqueous solution with one emission 
band, that of the ππ* transition, common for species with 
extended interannular conjugation. The solid state tetrazole 
provided the emission and excitation profiles shown in Figure 
4B. It can clearly be seen that this is very similar to the 
emission profile seen when the COM crystals are grown in 
the presence of the tetrazole (Figure 4C). Minor differences 
in the intensity of the aggregated peaks and the ππ* 
transition might be due to the different environments in which 
they are found. Additionally, upon exciting the COM crystals 
alone, we also determined that the signal seen in Figure 4C 
could not have come from COM as it does not emit at all, see 
Figure 5S†. Finally, to verify that the aggregated emission 
profile is not due to the difference between the tetrazole 
species in their tetrazolate state as opposed to the 
protonated state during crystallisation, the tetrazole species 
were dispersed in PMMA polymers in their protonated and 
deprotonated states and the results are shown for the 
tetrazolate species TzmeoxPh- in Figure 4D, while the 
protonated species is identical (Figure 6S†). Thus, in the 
COM crystal the tetrazole species is aggregated and the lack 
of an aggregated state between the protonated and 
deprotonated species verifies that the aggregation 
phenomenon is related to the interaction with COM crystals. 
This aggregation is seen in all of the tetrazole species 
investigated. 
Conclusion 
The photophysical investigation and exploration using CRM 
facilitated in probing the interactions between our tetrazole 
CGM’s and COM crystals. It was also established that our 
tetrazole species change the behaviour of the COM crystals 
during crystallisation mainly through a reduction in the 
number of particles formed. More importantly, our research 
determined that the strong adsorption interactions are 
followed by aggregation of the tetrazole within the crystal 
itself during growth. This is a unique mechanism of 
interaction which still has many aspects to be fully 
understood, an AFM investigation has begun to further 
elucidate this mechanism. Understanding of all the 
interactions involved would be highly beneficial in 
determining the extent of the morphological impact the 
adsorption process has alone, with and without the 
aggregation occurring. Once fully understood, the 
interactions could allow us to control COM crystallisation by 
inclusion of inhibitors into the lattice during growth or further 
yet by “activating” the aggregated species enveloped inside 
the crystals for controlled dissolution.  
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